Structure

Physi-Chem Properties

Molecular Weight:  582.16
Volume:  528.868
LogP:  -0.068
LogD:  -0.244
LogS:  -4.251
# Rotatable Bonds:  6
TPSA:  238.2
# H-Bond Aceptor:  15
# H-Bond Donor:  8
# Rings:  5
# Heavy Atoms:  15

MedChem Properties

QED Drug-Likeness Score:  0.147
Synthetic Accessibility Score:  4.714
Fsp3:  0.5
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.407
MDCK Permeability:  6.512366235256195e-05
Pgp-inhibitor:  0.001
Pgp-substrate:  0.997
Human Intestinal Absorption (HIA):  0.795
20% Bioavailability (F20%):  0.001
30% Bioavailability (F30%):  0.989

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.105
Plasma Protein Binding (PPB):  71.20027160644531%
Volume Distribution (VD):  0.691
Pgp-substrate:  19.91322135925293%

ADMET: Metabolism

CYP1A2-inhibitor:  0.07
CYP1A2-substrate:  0.124
CYP2C19-inhibitor:  0.02
CYP2C19-substrate:  0.296
CYP2C9-inhibitor:  0.002
CYP2C9-substrate:  0.538
CYP2D6-inhibitor:  0.021
CYP2D6-substrate:  0.187
CYP3A4-inhibitor:  0.01
CYP3A4-substrate:  0.005

ADMET: Excretion

Clearance (CL):  1.289
Half-life (T1/2):  0.541

ADMET: Toxicity

hERG Blockers:  0.227
Human Hepatotoxicity (H-HT):  0.095
Drug-inuced Liver Injury (DILI):  0.952
AMES Toxicity:  0.726
Rat Oral Acute Toxicity:  0.013
Maximum Recommended Daily Dose:  0.005
Skin Sensitization:  0.424
Carcinogencity:  0.033
Eye Corrosion:  0.003
Eye Irritation:  0.026
Respiratory Toxicity:  0.019

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC267254

Natural Product ID:  NPC267254
Common Name*:   7-O-(Alpha-L-Rhamnopyranosyl)-8-O-(Beta-D-Glucopyranosyl)-1-Hydroxy-3-Methoxyxanthone
IUPAC Name:   8-hydroxy-6-methoxy-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyxanthen-9-one
Synonyms:  
Standard InCHIKey:  HWWPEIMHGPFLAK-PZHXEPITSA-N
Standard InCHI:  InChI=1S/C26H30O15/c1-8-17(29)20(32)22(34)25(37-8)39-12-4-3-11-16(19(31)15-10(28)5-9(36-2)6-13(15)38-11)24(12)41-26-23(35)21(33)18(30)14(7-27)40-26/h3-6,8,14,17-18,20-23,25-30,32-35H,7H2,1-2H3/t8-,14+,17-,18+,20+,21-,22+,23+,25-,26-/m0/s1
SMILES:  COc1cc(O)c2c(c1)oc1c(c2=O)c(O[C@@H]2O[C@H](CO)[C@H]([C@@H]([C@H]2O)O)O)c(cc1)O[C@@H]1O[C@@H](C)[C@@H]([C@H]([C@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2409396
PubChem CID:   71745330
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0002817] Dibenzopyrans
            • [CHEMONTID:0000200] Xanthenes
              • [CHEMONTID:0000204] Xanthones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO9824 Swertia kouitchensis Species Gentianaceae Eukaryota n.a. n.a. n.a. PMID[23805995]
NPO9824 Swertia kouitchensis Species Gentianaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO9824 Swertia kouitchensis Species Gentianaceae Eukaryota n.a. n.a. n.a. Database[TCMID]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified IC50 = 714000.0 nM PMID[542965]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC267254 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9938 High Similarity NPC236191
0.9938 High Similarity NPC239549
0.9938 High Similarity NPC51774
0.9877 High Similarity NPC102028
0.9876 High Similarity NPC301683
0.9876 High Similarity NPC156977
0.9875 High Similarity NPC472383
0.9875 High Similarity NPC472381
0.9814 High Similarity NPC183357
0.9814 High Similarity NPC21190
0.9814 High Similarity NPC44558
0.9814 High Similarity NPC22195
0.9814 High Similarity NPC293004
0.9812 High Similarity NPC93099
0.9755 High Similarity NPC142996
0.9753 High Similarity NPC472386
0.9752 High Similarity NPC293629
0.9752 High Similarity NPC95855
0.9752 High Similarity NPC170675
0.9752 High Similarity NPC112755
0.9752 High Similarity NPC210042
0.9752 High Similarity NPC471457
0.9693 High Similarity NPC204693
0.9691 High Similarity NPC471416
0.9691 High Similarity NPC79056
0.9691 High Similarity NPC194483
0.9691 High Similarity NPC105095
0.9691 High Similarity NPC44328
0.9691 High Similarity NPC34287
0.9691 High Similarity NPC52353
0.9691 High Similarity NPC474434
0.9691 High Similarity NPC105511
0.9691 High Similarity NPC177731
0.9636 High Similarity NPC472387
0.9632 High Similarity NPC205076
0.9632 High Similarity NPC3583
0.9632 High Similarity NPC307518
0.9632 High Similarity NPC48773
0.9632 High Similarity NPC259152
0.9632 High Similarity NPC475155
0.963 High Similarity NPC201292
0.963 High Similarity NPC229687
0.963 High Similarity NPC43587
0.963 High Similarity NPC186807
0.963 High Similarity NPC226294
0.963 High Similarity NPC93337
0.963 High Similarity NPC105025
0.963 High Similarity NPC45638
0.963 High Similarity NPC61791
0.963 High Similarity NPC183036
0.963 High Similarity NPC475942
0.963 High Similarity NPC469931
0.963 High Similarity NPC58053
0.9627 High Similarity NPC236934
0.9627 High Similarity NPC70441
0.9627 High Similarity NPC5778
0.9576 High Similarity NPC169733
0.9576 High Similarity NPC472382
0.9576 High Similarity NPC472380
0.9576 High Similarity NPC472384
0.9571 High Similarity NPC224462
0.9571 High Similarity NPC51326
0.9571 High Similarity NPC231194
0.9568 High Similarity NPC135345
0.9568 High Similarity NPC58716
0.9568 High Similarity NPC45618
0.9568 High Similarity NPC45400
0.9568 High Similarity NPC146792
0.9518 High Similarity NPC476621
0.9518 High Similarity NPC476623
0.9518 High Similarity NPC475261
0.9518 High Similarity NPC476620
0.9518 High Similarity NPC476618
0.9518 High Similarity NPC476619
0.9518 High Similarity NPC476622
0.9512 High Similarity NPC172807
0.9512 High Similarity NPC211594
0.9512 High Similarity NPC117260
0.9512 High Similarity NPC256760
0.9512 High Similarity NPC476405
0.9512 High Similarity NPC254540
0.9509 High Similarity NPC195257
0.9509 High Similarity NPC209296
0.9509 High Similarity NPC105283
0.9506 High Similarity NPC115674
0.9506 High Similarity NPC99957
0.9506 High Similarity NPC181616
0.9506 High Similarity NPC210073
0.9503 High Similarity NPC243930
0.9503 High Similarity NPC29830
0.9503 High Similarity NPC88023
0.9503 High Similarity NPC309025
0.9503 High Similarity NPC127415
0.9461 High Similarity NPC470444
0.9461 High Similarity NPC473682
0.9461 High Similarity NPC473895
0.9461 High Similarity NPC126784
0.9461 High Similarity NPC470443
0.9461 High Similarity NPC110941
0.9461 High Similarity NPC241423
0.9461 High Similarity NPC473571
0.9458 High Similarity NPC65563
0.9458 High Similarity NPC268533
0.9458 High Similarity NPC8573
0.9458 High Similarity NPC470949
0.9455 High Similarity NPC101026
0.9455 High Similarity NPC42773
0.9455 High Similarity NPC45522
0.9455 High Similarity NPC21666
0.9455 High Similarity NPC24043
0.9455 High Similarity NPC208668
0.9455 High Similarity NPC169977
0.9451 High Similarity NPC199079
0.9451 High Similarity NPC84265
0.9451 High Similarity NPC150767
0.9451 High Similarity NPC78734
0.9451 High Similarity NPC245014
0.9451 High Similarity NPC282987
0.9451 High Similarity NPC210808
0.9448 High Similarity NPC229729
0.9448 High Similarity NPC477502
0.9444 High Similarity NPC165720
0.9444 High Similarity NPC284277
0.9444 High Similarity NPC311830
0.9444 High Similarity NPC22832
0.9444 High Similarity NPC475497
0.9444 High Similarity NPC475366
0.9441 High Similarity NPC127782
0.9441 High Similarity NPC300537
0.9408 High Similarity NPC148710
0.9405 High Similarity NPC473071
0.9405 High Similarity NPC473073
0.9401 High Similarity NPC168584
0.9398 High Similarity NPC264735
0.9398 High Similarity NPC472607
0.9398 High Similarity NPC477848
0.9398 High Similarity NPC198199
0.9394 High Similarity NPC180918
0.9394 High Similarity NPC9002
0.9394 High Similarity NPC257011
0.9394 High Similarity NPC288152
0.9394 High Similarity NPC261254
0.9394 High Similarity NPC137871
0.939 High Similarity NPC270578
0.939 High Similarity NPC86008
0.939 High Similarity NPC52382
0.9387 High Similarity NPC8856
0.9383 High Similarity NPC94777
0.9383 High Similarity NPC270335
0.9383 High Similarity NPC191306
0.9383 High Similarity NPC19709
0.9383 High Similarity NPC222936
0.9383 High Similarity NPC284960
0.9383 High Similarity NPC88043
0.9379 High Similarity NPC182045
0.9357 High Similarity NPC473618
0.9349 High Similarity NPC470449
0.9349 High Similarity NPC473072
0.9349 High Similarity NPC470445
0.9349 High Similarity NPC470447
0.9349 High Similarity NPC473883
0.9349 High Similarity NPC470446
0.9341 High Similarity NPC48984
0.9341 High Similarity NPC472385
0.9341 High Similarity NPC472991
0.9341 High Similarity NPC198324
0.9341 High Similarity NPC472992
0.9341 High Similarity NPC233994
0.9341 High Similarity NPC211532
0.9341 High Similarity NPC255799
0.9333 High Similarity NPC95866
0.9333 High Similarity NPC218488
0.9333 High Similarity NPC285197
0.9333 High Similarity NPC212748
0.9333 High Similarity NPC67105
0.9329 High Similarity NPC92565
0.9329 High Similarity NPC116745
0.9329 High Similarity NPC160156
0.9329 High Similarity NPC14662
0.9325 High Similarity NPC15358
0.9321 High Similarity NPC148273
0.9321 High Similarity NPC77660
0.9321 High Similarity NPC473043
0.9321 High Similarity NPC189142
0.9317 High Similarity NPC97285
0.9317 High Similarity NPC142860
0.9317 High Similarity NPC110349
0.9317 High Similarity NPC246469
0.9317 High Similarity NPC271270
0.9298 High Similarity NPC179947
0.9294 High Similarity NPC470455
0.9294 High Similarity NPC470451
0.9286 High Similarity NPC89052
0.9286 High Similarity NPC251417
0.9286 High Similarity NPC120952
0.9281 High Similarity NPC294815
0.9281 High Similarity NPC49344
0.9281 High Similarity NPC108202
0.9281 High Similarity NPC115760
0.9281 High Similarity NPC135277

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC267254 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9691 High Similarity NPD7074 Phase 3
0.9509 High Similarity NPD7054 Approved
0.9451 High Similarity NPD7472 Approved
0.9281 High Similarity NPD7808 Phase 3
0.9281 High Similarity NPD4338 Clinical (unspecified phase)
0.9277 High Similarity NPD6797 Phase 2
0.9222 High Similarity NPD7251 Discontinued
0.9212 High Similarity NPD3818 Discontinued
0.9091 High Similarity NPD6167 Clinical (unspecified phase)
0.9091 High Similarity NPD6166 Phase 2
0.9091 High Similarity NPD6168 Clinical (unspecified phase)
0.9074 High Similarity NPD4381 Clinical (unspecified phase)
0.8944 High Similarity NPD1934 Approved
0.8929 High Similarity NPD7804 Clinical (unspecified phase)
0.8889 High Similarity NPD2801 Approved
0.8773 High Similarity NPD2393 Clinical (unspecified phase)
0.8623 High Similarity NPD5494 Approved
0.8554 High Similarity NPD4868 Clinical (unspecified phase)
0.8494 Intermediate Similarity NPD3817 Phase 2
0.8476 Intermediate Similarity NPD4380 Phase 2
0.8448 Intermediate Similarity NPD6559 Discontinued
0.8443 Intermediate Similarity NPD3882 Suspended
0.8391 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD1511 Approved
0.8284 Intermediate Similarity NPD7075 Discontinued
0.8276 Intermediate Similarity NPD5844 Phase 1
0.8274 Intermediate Similarity NPD5402 Approved
0.8232 Intermediate Similarity NPD1512 Approved
0.8232 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8187 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8187 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.814 Intermediate Similarity NPD6959 Discontinued
0.8137 Intermediate Similarity NPD1549 Phase 2
0.8133 Intermediate Similarity NPD1653 Approved
0.8114 Intermediate Similarity NPD7228 Approved
0.8107 Intermediate Similarity NPD1465 Phase 2
0.8107 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8092 Intermediate Similarity NPD6232 Discontinued
0.8061 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8059 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8057 Intermediate Similarity NPD7473 Discontinued
0.8047 Intermediate Similarity NPD6801 Discontinued
0.8045 Intermediate Similarity NPD8312 Approved
0.8045 Intermediate Similarity NPD8313 Approved
0.8022 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8011 Intermediate Similarity NPD3751 Discontinued
0.8 Intermediate Similarity NPD7819 Suspended
0.7989 Intermediate Similarity NPD3787 Discontinued
0.7988 Intermediate Similarity NPD7411 Suspended
0.7964 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7931 Intermediate Similarity NPD7199 Phase 2
0.7926 Intermediate Similarity NPD6782 Approved
0.7926 Intermediate Similarity NPD6776 Approved
0.7926 Intermediate Similarity NPD6780 Approved
0.7926 Intermediate Similarity NPD6781 Approved
0.7926 Intermediate Similarity NPD6778 Approved
0.7926 Intermediate Similarity NPD6777 Approved
0.7926 Intermediate Similarity NPD6779 Approved
0.7901 Intermediate Similarity NPD2796 Approved
0.7892 Intermediate Similarity NPD6799 Approved
0.7887 Intermediate Similarity NPD7783 Phase 2
0.7887 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7857 Intermediate Similarity NPD5403 Approved
0.7844 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.784 Intermediate Similarity NPD1510 Phase 2
0.7836 Intermediate Similarity NPD37 Approved
0.7833 Intermediate Similarity NPD7685 Pre-registration
0.7816 Intermediate Similarity NPD6234 Discontinued
0.7803 Intermediate Similarity NPD4965 Approved
0.7803 Intermediate Similarity NPD4967 Phase 2
0.7803 Intermediate Similarity NPD4966 Approved
0.7801 Intermediate Similarity NPD7697 Approved
0.7801 Intermediate Similarity NPD7696 Phase 3
0.7801 Intermediate Similarity NPD7698 Approved
0.7801 Intermediate Similarity NPD7435 Discontinued
0.7797 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7784 Intermediate Similarity NPD8151 Discontinued
0.776 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.774 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7738 Intermediate Similarity NPD5401 Approved
0.7735 Intermediate Similarity NPD7240 Approved
0.7732 Intermediate Similarity NPD7701 Phase 2
0.7727 Intermediate Similarity NPD1247 Approved
0.7719 Intermediate Similarity NPD6599 Discontinued
0.7702 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7702 Intermediate Similarity NPD1240 Approved
0.7702 Intermediate Similarity NPD1613 Approved
0.7688 Intermediate Similarity NPD8455 Phase 2
0.7679 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7668 Intermediate Similarity NPD7871 Phase 2
0.7668 Intermediate Similarity NPD7870 Phase 2
0.766 Intermediate Similarity NPD6534 Approved
0.766 Intermediate Similarity NPD6535 Approved
0.7656 Intermediate Similarity NPD6823 Phase 2
0.764 Intermediate Similarity NPD3926 Phase 2
0.7636 Intermediate Similarity NPD7266 Discontinued
0.7632 Intermediate Similarity NPD7700 Phase 2
0.7632 Intermediate Similarity NPD7699 Phase 2
0.7607 Intermediate Similarity NPD1607 Approved
0.7605 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7593 Intermediate Similarity NPD943 Approved
0.759 Intermediate Similarity NPD7584 Approved
0.7576 Intermediate Similarity NPD2935 Discontinued
0.7563 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7563 Intermediate Similarity NPD7874 Approved
0.7557 Intermediate Similarity NPD3749 Approved
0.7546 Intermediate Similarity NPD1933 Approved
0.7525 Intermediate Similarity NPD7801 Approved
0.7516 Intermediate Similarity NPD3027 Phase 3
0.7514 Intermediate Similarity NPD919 Approved
0.75 Intermediate Similarity NPD3750 Approved
0.75 Intermediate Similarity NPD4628 Phase 3
0.75 Intermediate Similarity NPD7768 Phase 2
0.7485 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7456 Intermediate Similarity NPD6190 Approved
0.7453 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7439 Intermediate Similarity NPD230 Phase 1
0.7439 Intermediate Similarity NPD447 Suspended
0.7427 Intermediate Similarity NPD2532 Approved
0.7427 Intermediate Similarity NPD2534 Approved
0.7427 Intermediate Similarity NPD2533 Approved
0.7421 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7421 Intermediate Similarity NPD6212 Phase 3
0.7421 Intermediate Similarity NPD6213 Phase 3
0.7398 Intermediate Similarity NPD8319 Approved
0.7398 Intermediate Similarity NPD8320 Phase 1
0.7391 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7371 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7365 Intermediate Similarity NPD1551 Phase 2
0.7362 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.734 Intermediate Similarity NPD8150 Discontinued
0.7337 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7337 Intermediate Similarity NPD2800 Approved
0.732 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7297 Intermediate Similarity NPD5953 Discontinued
0.7259 Intermediate Similarity NPD7680 Approved
0.7257 Intermediate Similarity NPD7458 Discontinued
0.7257 Intermediate Similarity NPD3226 Approved
0.7249 Intermediate Similarity NPD8434 Phase 2
0.7241 Intermediate Similarity NPD920 Approved
0.7235 Intermediate Similarity NPD6674 Discontinued
0.7232 Intermediate Similarity NPD6844 Discontinued
0.7225 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7216 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7202 Intermediate Similarity NPD3748 Approved
0.72 Intermediate Similarity NPD7585 Approved
0.7198 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7189 Intermediate Similarity NPD7286 Phase 2
0.7168 Intermediate Similarity NPD7390 Discontinued
0.716 Intermediate Similarity NPD6100 Approved
0.716 Intermediate Similarity NPD6099 Approved
0.715 Intermediate Similarity NPD7583 Approved
0.7134 Intermediate Similarity NPD4908 Phase 1
0.7128 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7125 Intermediate Similarity NPD1091 Approved
0.7118 Intermediate Similarity NPD2344 Approved
0.7118 Intermediate Similarity NPD2346 Discontinued
0.7113 Intermediate Similarity NPD4360 Phase 2
0.7113 Intermediate Similarity NPD4363 Phase 3
0.7101 Intermediate Similarity NPD2799 Discontinued
0.7101 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7101 Intermediate Similarity NPD7033 Discontinued
0.71 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD6651 Approved
0.7073 Intermediate Similarity NPD9494 Approved
0.7065 Intermediate Similarity NPD5242 Approved
0.7056 Intermediate Similarity NPD5353 Approved
0.7048 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD2313 Discontinued
0.7048 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD7549 Discontinued
0.7035 Intermediate Similarity NPD5005 Approved
0.7035 Intermediate Similarity NPD5006 Approved
0.7035 Intermediate Similarity NPD1243 Approved
0.703 Intermediate Similarity NPD6832 Phase 2
0.7028 Intermediate Similarity NPD8058 Clinical (unspecified phase)
0.7028 Intermediate Similarity NPD8059 Phase 3
0.7019 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD2798 Approved
0.7011 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7011 Intermediate Similarity NPD5710 Approved
0.7011 Intermediate Similarity NPD5711 Approved
0.7006 Intermediate Similarity NPD6233 Phase 2
0.7 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.6994 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6983 Remote Similarity NPD7615 Clinical (unspecified phase)
0.697 Remote Similarity NPD2861 Phase 2
0.6966 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6957 Remote Similarity NPD8127 Discontinued
0.6954 Remote Similarity NPD2309 Approved
0.6951 Remote Similarity NPD1203 Approved
0.6946 Remote Similarity NPD6798 Discontinued
0.6943 Remote Similarity NPD6841 Approved
0.6943 Remote Similarity NPD6842 Approved
0.6943 Remote Similarity NPD6843 Phase 3
0.6941 Remote Similarity NPD7097 Phase 1
0.6936 Remote Similarity NPD1652 Phase 2
0.6933 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6932 Remote Similarity NPD7422 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data